Stockreport
INSYS Therapeutics Appoints Trudy Vanhove to Board of Directors
Last insys therapeutics, inc earnings: 11/5 04:16 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.insysrx.com
PDF
PHOENIX, April 02, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced the appointment of Trudy Vanhove as a new independent member of its Board of Directors. Given her extensive experience in clinical development and medical affairs, Dr. Vanhove will also serve on the Board’s R&D committee. “Trudy’s deep understanding and knowledge of pharmaceutical drug discovery, development and education from her more than 20-year career in the industry will greatly enhance the company’s expertise in this critically important functional area,” said Steven Meyer, chairman of the INSYS Therapeutics Board of Directors. “We look forward to her insightful contributions.” Dr. Vanhove has served as a vice president of medical affairs and, subsequently, R&D search and evaluation at Jazz Pharmaceuticals in Palo Alto, Calif. since 2012. She began her career at
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | INSY | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
INSY alerts
INSY alerts
from News Quantified
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INSY alerts
High impacting Insys Therapeutics, Inc news events
Weekly update
A roundup of the hottest topics
INSY
NEWS
NEWS
- Insys stock drops 27% after auditor questions company's viability [MarketWatch][MarketWatch]
- UPDATE 1-Insys Therapeutics' auditor raises going concern doubts, shares drop [Reuters][Reuters]
- Insys Therapeutics Inc (NASDAQ: INSY) was given a new $4.00 price target on by analysts at Piper Jaffray Companies. They now have a "sell" rating on the stock.[MarketBeat]
- Insys Therapeutics Inc (NASDAQ: INSY) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating.[MarketBeat]
- Insys Therapeutics (INSY) Q4 2018 Earnings Conference Call Transcript [The Motley Fool][The Motley Fool]
- More
INSY
SEC Filings
SEC Filings
- 3/13/19 - Form 10-K
- 3/7/19 - Form 8-K
- 3/7/19 - Form SC
- INSY's page on the SEC website
- More